APVO
Aptevo Therapeutics Inc.
Company overview
- Market capitalization
- $3.44M
- Employees
- 33
- Latest publication
- 2026-09-29
About Aptevo Therapeutics Inc.
Aptevo Therapeutics Inc., a clinical-stage research and development biotechnology company, focuses on developing immunotherapeutic candidates for the treatment of various forms of cancer in the United States. The company develops its products using ADAPTIR and ADAPTIR-FLEX platforms to generate monospecific, bispecific, and multi-specific antibody candidates capable of enhancing the human immune system against cancer cells. Its lead clinical blood cancer candidate is mipletamig that is in Phase 1b/2 clinical trial for the treatment of acute myelogenous leukemia. The company also develops ALG.APV-527, a novel investigational bispecific ADAPTIR candidate that is in Phase 1 clinical trial for the treatment malignant pleural mesothelioma, non-small cell lung, gastric/gastro-esophageal, head and neck squamous cell carcinoma, pancreatic, renal, ovarian, prostate, breast, cervical, colorectal, endometrial, and bladder cancers; APVO603, a preclinical dual agonist bispecific ADAPTIR candidate to treat multiple solid tumors; APVO442, a preclinical bispecific candidate based on the ADAPTIR-FLEX platform technology for the treatment of multiple solid tumors; and APVO711, a preclinical dual mechanism bispecific ADAPTIR candidate to treat prostate cancer. It has a collaboration and option agreement with Alligator Bioscience AB to develop ALG.APV-527. Aptevo Therapeutics Inc. was incorporated in 2016 and is headquartered in Seattle, Washington.
Financial statements
Income Quarterly
| Metric | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD | Q2 20242024-06-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 0USD | -220,000USD | 0USD | 0USD | 0USD | 0USD | 0USD | 0USD |
| Cost Of Revenue | 35,000USD | 81,000USD | — | 49,000USD | 61,000USD | 71,000USD | 54,000USD | 91,000USD |
| Gross Profit | -35,000USD | -81,000USD | — | -49,000USD | -61,000USD | -71,000USD | -54,000USD | 106,000USD |
| Research Development | 3,889,000USD | 3,535,000USD | 4,044,000USD | 3,328,000USD | 3,633,000USD | 3,880,000USD | 3,103,000USD | 3,643,000USD |
| Selling General Administrative | 2,913,000USD | 2,461,000USD | 3,566,000USD | 2,898,000USD | 2,847,000USD | 2,502,000USD | 2,110,000USD | 2,381,000USD |
| Total Operating Expenses | 6,802,000USD | 5,915,000USD | 7,610,000USD | 6,226,000USD | 6,480,000USD | 6,311,000USD | 5,213,000USD | 6,024,000USD |
| Operating Income | -6,837,000USD | -5,996,000USD | -7,610,000USD | -6,226,000USD | -6,480,000USD | -6,382,000USD | -5,213,000USD | -6,024,000USD |
| Income Before Tax | -6,697,000USD | -5,806,000USD | -7,549,000USD | -6,204,000USD | -6,408,000USD | -6,312,000USD | -5,101,000USD | -5,883,000USD |
| Net Income | -6,697,000USD | -5,806,000USD | -7,549,000USD | -6,204,000USD | -6,408,000USD | -6,312,000USD | -5,101,000USD | -5,883,000USD |
| Net Income From Continuing Ops | -6,697,000USD | -5,806,000USD | -7,549,000USD | -6,204,000USD | -6,408,000USD | -6,312,000USD | -5,101,000USD | -5,883,000USD |
| Ebit | -6,837,000USD | -5,967,000USD | -7,549,000USD | -6,226,000USD | -6,480,000USD | -6,382,000USD | -5,213,000USD | -6,024,000USD |
| Ebitda | -6,802,000USD | -5,886,000USD | -7,500,000USD | -6,177,000USD | -6,419,000USD | -6,311,000USD | -5,129,000USD | -5,933,000USD |
| Depreciation And Amortization | 35,000USD | 81,000USD | 49,000USD | 49,000USD | 61,000USD | 71,000USD | 84,000USD | 91,000USD |
| Reconciled Depreciation | 35,000USD | 81,000USD | 49,000USD | 49,000USD | 61,000USD | 71,000USD | 84,000USD | 91,000USD |
| Total Other Income Expense Net | 140,000USD | 190,000USD | 61,000USD | 22,000USD | 72,000USD | 70,000USD | 112,000USD | 141,000USD |
| Income Tax Expense | — | — | — | — | — | — | — | -62,724USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Income Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 0USD | 0USD | 0USD | 3,114,000USD | 12,292,000USD | 4,309,000USD | 32,424,000USD | 23,067,000USD |
| Cost Of Revenue | 240,000USD | 352,000USD | 17,107,000USD | 17,882,000USD | 18,994,000USD | 17,852,000USD | 2,235,000USD | 11,214,000USD |
| Gross Profit | -240,000USD | -352,000USD | -567,000USD | 3,114,000USD | 12,292,000USD | -13,543,000USD | -2,235,000USD | 11,853,000USD |
| Research Development | 14,540,000USD | 14,378,000USD | 17,107,000USD | 17,882,000USD | 18,994,000USD | 17,852,000USD | 24,763,000USD | 35,385,000USD |
| Selling General Administrative | 11,772,000USD | 10,224,000USD | 11,771,000USD | 13,873,000USD | 14,698,000USD | 13,951,000USD | 16,199,000USD | 28,133,000USD |
| Total Operating Expenses | 26,072,000USD | 24,250,000USD | 28,878,000USD | 31,755,000USD | 33,692,000USD | 13,951,000USD | 38,727,000USD | 63,518,000USD |
| Operating Income | -26,312,000USD | -24,602,000USD | -28,878,000USD | -28,641,000USD | -21,400,000USD | -27,494,000USD | -40,962,000USD | -51,665,000USD |
| Income Before Tax | -25,967,000USD | -24,130,000USD | -18,650,000USD | 7,014,000USD | -29,408,000USD | -30,923,000USD | -43,064,000USD | -53,689,000USD |
| Net Income | -25,967,000USD | -24,130,000USD | -17,411,000USD | 8,027,000USD | -27,313,000USD | -17,750,000USD | -44,698,000USD | -53,689,000USD |
| Net Income From Continuing Ops | -25,967,000USD | -24,130,000USD | -17,617,000USD | 7,014,000USD | -29,408,000USD | -30,923,000USD | -44,698,000USD | -53,689,000USD |
| Ebit | -26,312,000USD | -24,130,000USD | -28,878,000USD | -28,641,000USD | -21,400,000USD | -27,494,000USD | -43,064,000USD | -51,665,000USD |
| Ebitda | -26,072,000USD | -23,778,000USD | -28,311,000USD | -27,740,000USD | -20,256,000USD | -26,188,000USD | -40,829,000USD | -49,275,000USD |
| Depreciation And Amortization | 240,000USD | 352,000USD | 567,000USD | 901,000USD | 1,144,000USD | 1,306,000USD | 2,235,000USD | 2,390,000USD |
| Reconciled Depreciation | 240,000USD | 352,000USD | 612,000USD | 901,000USD | 1,144,000USD | 1,406,000USD | 2,235,000USD | 2,390,000USD |
| Total Other Income Expense Net | 345,000USD | 472,000USD | 10,228,000USD | 35,655,000USD | -8,008,000USD | -3,429,000USD | -2,102,000USD | -2,024,000USD |
| Income Tax Expense | — | — | -1,239,000USD | -35,655,000USD | -2,095,000USD | -12,475,000USD | -2,616,000USD | -23,301,000USD |
| Interest Expense | — | — | — | 35,655,000USD | 7,057,000USD | 0USD | 0USD | 0USD |
| Discontinued Operations | — | — | — | 1,013,000USD | 951,000USD | 13,173,000USD | 4,250,000USD | 4,250,000USD |
| Net Income Applicable To Common Shares | — | — | — | 8,027,000USD | -28,457,000USD | -17,750,000USD | -40,448,000USD | -53,689,000USD |
| Unclassified Operating Expenses | — | — | — | — | — | -17,852,000USD | -2,235,000USD | — |
| Non Operating Income Net Other | — | — | — | — | — | — | -2,102,000USD | -2,024,000USD |
| Tax Provision | — | — | — | — | — | — | — | 0USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Quarterly
| Metric | Q2 20262026-06-30 · USD | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 14,519,000USD | 19,902,000USD | 27,194,000USD | 26,996,000USD | 15,624,000USD | 8,342,000USD | 15,591,000USD | 15,146,000USD |
| Cash And Equivalents | 9,797,000USD | — | — | — | — | — | — | — |
| Total Current Assets | 10,798,000USD | 15,984,000USD | 23,081,000USD | 22,649,000USD | 11,081,000USD | 3,607,000USD | 10,659,000USD | 10,012,000USD |
| Other Current Assets | 462,000USD | 1,459,000USD | 1,462,000USD | 1,588,000USD | 1,671,000USD | 1,468,000USD | 1,945,000USD | 2,259,000USD |
| Total Liabilities | 8,478,000USD | — | — | — | — | — | — | — |
| Total Current Liabilities | 5,188,000USD | 4,760,000USD | 6,050,000USD | 5,614,000USD | 4,891,000USD | 5,393,000USD | 6,207,000USD | 5,882,000USD |
| Total Stockholder Equity | 6,041,000USD | 11,612,000USD | 17,381,000USD | 17,392,000USD | 6,524,000USD | -1,473,000USD | 4,755,000USD | 4,420,000USD |
| Total Equity Including Noncontrolling Interest | 6,041,000USD | — | — | — | — | — | — | — |
| Property Plant Equipment Net | 3,720,000USD | 3,918,000USD | 4,113,000USD | 4,347,000USD | 4,543,000USD | 4,735,000USD | 4,932,000USD | 5,134,000USD |
| Accounts Payable | 1,162,000USD | 890,000USD | 877,000USD | 2,219,000USD | 2,903,000USD | 3,789,000USD | 3,053,000USD | 3,532,000USD |
| Short Term Debt | 919,000USD | 892,000USD | 866,000USD | — | — | — | — | — |
| Common Stock | 114,000USD | 114,000USD | 114,000USD | 110,000USD | 99,000USD | 84,000USD | 84,000USD | 82,000USD |
| Retained Earnings | -288,264,000USD | -281,909,000USD | -275,115,000USD | -269,217,000USD | -260,189,000USD | -253,985,000USD | -247,577,000USD | -241,265,000USD |
| Total Liab | — | 8,290,000USD | 9,813,000USD | 9,604,000USD | 9,100,000USD | 9,815,000USD | 10,836,000USD | 10,726,000USD |
| Other Current Liab | — | 2,978,000USD | 4,307,000USD | 3,395,000USD | 1,988,000USD | 1,604,000USD | 3,154,000USD | 2,350,000USD |
| Capital Stock | — | 114,000USD | 114,000USD | 110,000USD | 99,000USD | 84,000USD | 84,000USD | 82,000USD |
| Cash | — | 14,525,000USD | 21,619,000USD | 21,061,000USD | 9,410,000USD | 2,139,000USD | 8,714,000USD | 7,753,000USD |
| Cash And Short Term Investments | — | 14,525,000USD | 21,619,000USD | 21,061,000USD | 9,410,000USD | 2,139,000USD | 8,714,000USD | 7,753,000USD |
| Net Debt | — | -10,103,000USD | -16,990,000USD | -17,071,000USD | -5,201,000USD | 2,283,000USD | -4,085,000USD | -2,923,000USD |
| Short Long Term Debt Total | — | 4,422,000USD | 4,629,000USD | 3,990,000USD | 4,209,000USD | 4,422,000USD | 4,629,000USD | 4,830,000USD |
| Property Plant Equipment Gross | — | 3,918,000USD | 18,256,000USD | 4,347,000USD | 4,543,000USD | 4,735,000USD | 18,877,000USD | 5,134,000USD |
| Common Stock Shares Outstanding | — | 1,060,678shares | 3,155shares | 224,946shares | 41,008shares | 4,051shares | 4,051shares | 792shares |
| Non Current Assets Total | — | 3,918,000USD | 4,113,000USD | 4,347,000USD | 4,543,000USD | 4,735,000USD | 4,932,000USD | 5,134,000USD |
| Non Current Liabilities Total | — | 3,530,000USD | 3,763,000USD | 3,990,000USD | 4,209,000USD | 4,422,000USD | 4,629,000USD | 4,844,000USD |
| Net Working Capital | — | 11,224,000USD | 17,031,000USD | 17,035,000USD | 6,190,000USD | -1,786,000USD | 4,452,000USD | 4,130,000USD |
| Unclassified Non Current Liabilities | — | 3,530,000USD | 3,763,000USD | 3,990,000USD | 4,209,000USD | 4,422,000USD | 4,629,000USD | 4,830,000USD |
| Unclassified Equity | — | 293,293,000USD | 292,268,000USD | 286,389,000USD | 266,515,000USD | 252,344,000USD | 252,164,000USD | 245,521,000USD |
| Accumulated Other Comprehensive Income | — | — | — | 0USD | — | — | — | — |
| Non Current Liabilities Other | — | — | — | — | — | — | — | 14,000USD |
| Source | DisclosureDeterministicFinal | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 27,194,000USD | 15,591,000USD | 24,842,000USD | 34,215,000USD | 56,601,000USD | 53,547,000USD | 53,408,000USD | 67,494,000USD |
| Other Current Assets | 1,462,000USD | 1,945,000USD | 2,162,000USD | 2,315,000USD | 3,862,000USD | 4,916,000USD | 4,386,000USD | 11,049,000USD |
| Total Liab | 9,813,000USD | 10,836,000USD | 12,621,000USD | 16,241,000USD | 55,385,000USD | 36,953,000USD | 41,566,000USD | 37,088,000USD |
| Total Stockholder Equity | 17,381,000USD | 4,755,000USD | 12,221,000USD | 17,974,000USD | 1,216,000USD | 16,594,000USD | 11,842,000USD | 30,406,000USD |
| Other Current Liab | 4,307,000USD | 3,154,000USD | 7,224,000USD | 6,706,000USD | 23,090,000USD | 9,539,000USD | 5,333,000USD | 5,939,000USD |
| Common Stock | 114,000USD | 84,000USD | 61,000USD | 48,000USD | 47,000USD | 46,000USD | 45,000USD | 23,000USD |
| Capital Stock | 114,000USD | 84,000USD | 61,000USD | 48,000USD | 47,000USD | 46,000USD | 45,000USD | 23,000USD |
| Retained Earnings | -275,115,000USD | -247,577,000USD | -223,447,000USD | -206,036,000USD | -214,063,000USD | -185,606,000USD | -167,856,000USD | -127,408,000USD |
| Cash | 21,619,000USD | 8,714,000USD | 16,904,000USD | 22,635,000USD | 45,044,000USD | 39,979,000USD | 12,448,000USD | 30,635,000USD |
| Cash And Short Term Investments | 21,619,000USD | 8,714,000USD | 16,904,000USD | 22,635,000USD | 45,044,000USD | 39,979,000USD | 12,448,000USD | 30,635,000USD |
| Total Current Assets | 23,081,000USD | 10,659,000USD | 19,066,000USD | 27,450,000USD | 52,570,000USD | 47,264,000USD | 29,995,000USD | 48,689,000USD |
| Total Current Liabilities | 6,050,000USD | 6,207,000USD | 7,224,000USD | 8,706,000USD | 34,757,000USD | 14,539,000USD | 38,239,000USD | 17,610,000USD |
| Net Debt | -16,990,000USD | -4,085,000USD | -11,507,000USD | -13,100,000USD | -28,329,000USD | -12,565,000USD | 10,742,000USD | -11,357,000USD |
| Short Term Debt | 866,000USD | — | — | 2,000,000USD | 11,667,000USD | 5,000,000USD | 19,863,000USD | 3,333,000USD |
| Short Long Term Debt Total | 4,629,000USD | 4,629,000USD | 5,397,000USD | 9,535,000USD | 16,715,000USD | 27,414,000USD | 23,190,000USD | 19,278,000USD |
| Accounts Payable | 877,000USD | 3,053,000USD | 3,984,000USD | 3,499,000USD | 3,462,000USD | 5,583,000USD | 13,043,000USD | 11,671,000USD |
| Property Plant Equipment Net | 4,113,000USD | 4,932,000USD | 5,776,000USD | 6,765,000USD | 3,963,000USD | 5,537,000USD | 7,693,000USD | 5,202,000USD |
| Property Plant Equipment Gross | 18,256,000USD | 18,877,000USD | 19,369,000USD | 19,791,000USD | 3,963,000USD | 2,815,000USD | 7,693,000USD | 5,202,000USD |
| Common Stock Shares Outstanding | 3,155shares | 767shares | 21shares | 9shares | 8shares | 6shares | 6shares | 49shares |
| Non Current Assets Total | 4,113,000USD | 4,932,000USD | 5,776,000USD | 6,765,000USD | 4,031,000USD | 6,283,000USD | 23,413,000USD | 18,805,000USD |
| Non Current Liabilities Total | 3,763,000USD | 4,629,000USD | 5,397,000USD | 7,535,000USD | 20,628,000USD | 22,414,000USD | 3,327,000USD | 19,478,000USD |
| Net Working Capital | 17,031,000USD | 4,452,000USD | 11,842,000USD | 18,744,000USD | 17,813,000USD | 32,725,000USD | -8,244,000USD | 31,079,000USD |
| Unclassified Non Current Liabilities | 3,763,000USD | 4,629,000USD | 5,397,000USD | 6,079,000USD | -14,239,000USD | 2,360,000USD | — | — |
| Unclassified Equity | 292,268,000USD | 252,164,000USD | 235,546,000USD | 223,914,000USD | 215,185,000USD | 202,108,000USD | 189,532,000USD | 157,873,000USD |
| Unclassified Current Liabilities | — | — | -3,984,000USD | -5,499,000USD | -15,129,000USD | -10,583,000USD | -19,863,000USD | -3,333,000USD |
| Current Deferred Revenue | — | — | — | -3,499,000USD | -3,462,000USD | -5,583,000USD | -3,745,000USD | -7,350,000USD |
| Short Long Term Debt | — | — | — | 2,000,000USD | 11,667,000USD | 5,000,000USD | 19,863,000USD | — |
| Long Term Debt | — | — | — | 1,456,000USD | 3,707,000USD | 20,054,000USD | — | 19,278,000USD |
| Net Receivables | — | — | — | 2,500,000USD | 3,664,000USD | 2,369,000USD | 7,022,000USD | 5,220,000USD |
| Inventory | — | — | — | 1,571,000USD | 3,082,000USD | 4,783,000USD | 6,139,000USD | 1,785,000USD |
| Non Currrent Assets Other | — | — | — | -6,765,000USD | 68,000USD | 746,000USD | 11,300,000USD | 8,353,000USD |
| Net Tangible Assets | — | — | — | 17,974,000USD | 1,216,000USD | 16,594,000USD | 7,422,000USD | 25,156,000USD |
| Unclassified Current Assets | — | — | — | -1,571,000USD | -3,082,000USD | -4,783,000USD | — | -73,688,000USD |
| Other Liab | — | — | — | — | 15,580,000USD | — | — | 200,000USD |
| Other Assets | — | — | — | — | 68,000USD | 3,468,000USD | 11,300,000USD | 8,353,000USD |
| Non Current Liabilities Other | — | — | — | — | 15,580,000USD | — | 3,327,000USD | 200,000USD |
| Unclassified Non Current Assets | — | — | — | — | — | -3,468,000USD | -11,300,000USD | -8,353,000USD |
| Intangible Assets | — | — | — | — | — | — | 4,420,000USD | 5,250,000USD |
| Accumulated Other Comprehensive Income | — | — | — | — | — | — | -9,924,000USD | -105,000USD |
| Short Term Investments | — | — | — | — | — | — | — | 73,688,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow YTD
| Metric | Q2 20262026-06-30 · USD |
|---|---|
| Depreciation | 67,000USD |
| Stock Based Compensation | 115,000USD |
| Change To Liabilities | -861,000USD |
| Change In Working Capital | 745,000USD |
| Operating Cash Flow | -13,419,000USD |
| Investing Cash Flow | 0USD |
| Financing Cash Flow | 1,597,000USD |
| Change In Cash | -11,822,000USD |
| End Cash Flow | 9,797,000USD |
| Source | DisclosureDeterministicFinal |
Cash flow Quarterly
| Metric | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD | Q2 20242024-06-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Net Income | -6,794,000USD | -5,806,000USD | -7,549,000USD | -6,204,000USD | -6,408,000USD | -6,312,000USD | -5,101,000USD | -5,883,000USD |
| Depreciation | 35,000USD | 81,000USD | 49,000USD | 49,000USD | 61,000USD | 71,000USD | 84,000USD | 91,000USD |
| Stock Based Compensation | 57,000USD | 2,000USD | 77,000USD | -163,000USD | 180,000USD | -72,000USD | 149,000USD | 273,000USD |
| Other Non Cash Items | 425,000USD | 1,089,000USD | 366,000USD | — | -814,000USD | 554,000USD | -1,630,000USD | 1,334,000USD |
| Change In Working Capital | -1,631,000USD | -602,000USD | 735,000USD | -775,000USD | 406,000USD | 554,000USD | 1,276,000USD | -634,000USD |
| Total Cash From Operating Activities | -7,965,000USD | -5,236,000USD | -6,688,000USD | -7,093,000USD | -6,575,000USD | -5,759,000USD | -5,222,000USD | -6,153,000USD |
| Capital Expenditures | 0USD | 0USD | 0USD | 0USD | 0USD | 0USD | 0USD | 0USD |
| Free Cash Flow | -7,965,000USD | -5,236,000USD | -6,688,000USD | -7,093,000USD | -6,575,000USD | -5,759,000USD | -5,222,000USD | -6,153,000USD |
| Total Cash From Financing Activities | 871,000USD | 5,794,000USD | 18,339,000USD | 14,364,000USD | 0USD | 6,720,000USD | 4,909,000USD | 3,969,000USD |
| Dividends Paid | -97,000USD | -92,000USD | -1,479,000USD | — | — | — | — | — |
| Issuance Of Capital Stock | 872,000USD | 5,237,000USD | 18,339,000USD | 14,364,000USD | 0USD | 1,157,000USD | 4,909,000USD | 3,970,000USD |
| Change In Cash | -7,094,000USD | 558,000USD | 11,651,000USD | 7,271,000USD | -6,575,000USD | 961,000USD | -313,000USD | -2,184,000USD |
| Begin Period Cash Flow | 21,619,000USD | 21,061,000USD | 9,410,000USD | 2,139,000USD | 8,714,000USD | 7,753,000USD | 8,066,000USD | 10,250,000USD |
| End Period Cash Flow | 14,525,000USD | 21,619,000USD | 21,061,000USD | 9,410,000USD | 2,139,000USD | 8,714,000USD | 7,753,000USD | 8,066,000USD |
| Other Cashflows From Financing Activities | -1,000USD | 557,000USD | 19,818,000USD | — | — | 5,563,000USD | -1,000USD | -1,000USD |
| Investments | — | — | 0USD | 0USD | 0USD | 0USD | 0USD | 0USD |
| Unclassified Financing Cash Flow | — | — | -18,339,000USD | — | — | — | 4,909,000USD | 3,971,000USD |
| Net Borrowings | — | — | — | — | — | 0USD | 0USD | — |
| Sale Purchase Of Stock | — | — | — | — | — | — | 1,000USD | -1,000USD |
| Unclassified Operating Cash Flow | — | — | — | — | — | — | — | -1,334,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Net Income | -25,967,000USD | -24,130,000USD | -17,411,000USD | 8,027,000USD | -28,457,000USD | -17,750,000USD | -40,448,000USD | -53,689,000USD |
| Depreciation | 240,000USD | 352,000USD | 567,000USD | 901,000USD | 1,144,000USD | 1,306,000USD | 2,235,000USD | 2,390,000USD |
| Stock Based Compensation | 96,000USD | 1,069,000USD | 2,193,000USD | 1,802,000USD | 1,643,000USD | 1,255,000USD | 1,598,000USD | 2,140,000USD |
| Other Non Cash Items | 1,089,000USD | -1,076,000USD | 10,000USD | -33,896,000USD | 6,642,000USD | -12,425,000USD | -3,577,000USD | 988,000USD |
| Change In Working Capital | -1,050,000USD | -1,076,000USD | 2,911,000USD | 2,144,000USD | -2,655,000USD | -1,704,000USD | -2,191,000USD | -3,251,000USD |
| Total Cash From Operating Activities | -25,592,000USD | -23,785,000USD | -11,730,000USD | -21,022,000USD | -21,679,000USD | -29,318,000USD | -42,383,000USD | -51,422,000USD |
| Capital Expenditures | 0USD | 0USD | 0USD | -29,000USD | -713,000USD | -88,000USD | -153,000USD | -976,000USD |
| Free Cash Flow | -25,592,000USD | -23,785,000USD | -11,730,000USD | -21,051,000USD | -22,392,000USD | -29,406,000USD | -42,536,000USD | -52,398,000USD |
| Total Cash From Financing Activities | 38,497,000USD | 15,595,000USD | 5,998,000USD | -2,616,000USD | 26,161,000USD | 23,874,000USD | 20,149,000USD | -787,000USD |
| Dividends Paid | -1,571,000USD | — | — | -4,000USD | -10,233,000USD | -21,247,000USD | -58,000USD | — |
| Issuance Of Capital Stock | 37,940,000USD | 10,036,000USD | 9,780,000USD | 6,934,000USD | 10,233,000USD | 23,000USD | 20,344,000USD | — |
| Change In Cash | 12,905,000USD | -8,190,000USD | -5,732,000USD | -23,667,000USD | 3,769,000USD | 22,588,000USD | -18,137,000USD | 20,588,000USD |
| Begin Period Cash Flow | 8,714,000USD | 16,904,000USD | 22,636,000USD | 46,303,000USD | 42,534,000USD | 19,946,000USD | 38,083,000USD | 17,495,000USD |
| End Period Cash Flow | 21,619,000USD | 8,714,000USD | 16,904,000USD | 22,636,000USD | 46,303,000USD | 42,534,000USD | 19,946,000USD | 38,083,000USD |
| Other Cashflows From Financing Activities | 1,571,000USD | 5,559,000USD | 3,037,000USD | 2,717,000USD | 26,478,000USD | 21,258,000USD | -58,000USD | -1,410,000USD |
| Investments | — | 0USD | 0USD | -29,000USD | -713,000USD | 28,032,000USD | 4,097,000USD | 73,708,000USD |
| Net Borrowings | — | 0USD | -3,467,000USD | -12,267,000USD | -10,550,000USD | 2,627,000USD | -137,000USD | -137,000USD |
| Unclassified Operating Cash Flow | — | 1,076,000USD | — | — | — | — | — | — |
| Change To Account Receivables | — | — | 2,500,000USD | 1,164,000USD | -1,295,000USD | -2,369,000USD | -1,802,000USD | -3,079,000USD |
| Sale Purchase Of Stock | — | — | -10,000USD | -4,000USD | 10,233,000USD | -11,000USD | -58,000USD | -758,000USD |
| Unclassified Financing Cash Flow | — | — | 6,438,000USD | 6,942,000USD | 10,233,000USD | 21,247,000USD | 20,460,000USD | 1,518,000USD |
| Change To Inventory | — | — | — | -1,164,000USD | 1,295,000USD | -1,054,000USD | -4,354,000USD | -757,000USD |
| Change To Liabilities | — | — | — | -394,000USD | -1,915,000USD | -702,000USD | 938,000USD | 1,279,000USD |
| Total Cashflows From Investing Activities | — | — | — | -29,000USD | -713,000USD | 28,032,000USD | 4,097,000USD | 72,797,000USD |
| Other Cashflows From Investing Activities | — | — | — | — | — | 28,120,000USD | 4,250,000USD | 73,773,000USD |
| Unclassified Investing Cash Flow | — | — | — | — | — | -28,032,000USD | -4,097,000USD | -73,708,000USD |
| Cash And Cash Equivalents Changes | — | — | — | — | — | — | -18,137,000USD | 20,588,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Operating metrics
No operating metrics are currently published for this company.
Revenue breakdown
| Period | Dimension | Business / region | Revenue | Currency | Source |
|---|---|---|---|---|---|
| FY 2017Yearly · 2017-12-31 | Product | Collaboration Revenue | 3,709,000 | USD | 0001564590-19-008184 |
| FY 2017Yearly · 2017-12-31 | Product | Product | 10,949,000 | USD | 0001564590-19-008184 |
| Q3 2017Quarterly · 2017-09-30 | Product | Collaboration Revenue | 3,666,000 | USD | 0001564590-18-029562 |
| Q3 2017Quarterly · 2017-09-30 | Product | Product | 2,506,000 | USD | 0001564590-18-029562 |
| Q2 2017Quarterly · 2017-06-30 | Product | Collaboration Revenue | 14,000 | USD | 0001564590-18-020781 |
| Q2 2017Quarterly · 2017-06-30 | Product | Product | 3,512,000 | USD | 0001564590-18-020781 |
Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.